483 Lifecore Biomedical Feb 2017

483 Lifecore Biomedical Feb 2017

Scott Golladay FDA$119.00 - Available Now

FDA investigators audited the Lifecore Biomedical - Chaska, MN, United States facility and issued inspectional observations (via FDA 483) on 22 Feb 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Feb 2017
  • Location: Chaska, United States
  • FEI: 3012276274
Add To Cart